For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Adicet Bio Inc’s stock clocked out at $0.92, down -5.01% from its previous closing price of $0.97. In other words, the price has decreased by -$5.01 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
To gain a deeper understanding of ACET’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.64 and its Current Ratio is at 10.64. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 05 ’24 when Kauffman Michael sold 5,900 shares for $1.43 per share. The transaction valued at 8,437 led to the insider holds 5,900 shares of the business.
Stock Price History:
Over the past 52 weeks, ACET has reached a high of $2.74, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -1.81%, while the 200-Day Moving Average is calculated to be -26.51%.
Shares Statistics:
A total of 82.40M shares are outstanding, with a floating share count of 65.13M. Insiders hold about 20.96% of the company’s shares, while institutions hold 50.76% stake in the company.
Earnings Estimates
Currently, 4.0 analysts are dedicated to thoroughly evaluating and rating the performance of Adicet Bio Inc (ACET) in the stock market.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.36 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$1.23 and -$1.39 for the fiscal current year, implying an average EPS of -$1.34. EPS for the following year is -$1.37, with 6.0 analysts recommending between -$1.08 and -$1.56.
